Guardant Health, Inc. Company Review & Valuation
About Guardant Health, Inc.
Guardant Health, Inc., a precision oncology company, provides non-invasive cancer diagnostics.
It offers liquid biopsy tests for advanced stage cancer, such as Guardant360, a molecular diagnostic test that measures various cancer-related genes from circulating tumor DNA (ctDNA); and GuardantOMNI, a broader panel measuring various genes from ctDNA.
The company also provides LUNAR-1 for recurrence detection in cancer survivors; and LUNAR-2 for early detection of cancer in higher risk individuals.
Guardant Health, Inc.
was incorporated in 2011 and is headquartered in Redwood City, California.